Legacy Laboratory Services, LLC

Legacy Laboratory Services, LLC was paid $24.82M by Medicaid between Jan 2018 and Nov 2023, across 283 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 10% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Oregon

Rank by total paid#4 of 46

Median peer was paid$50K

This provider vs. median497×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	422,245	$4.50M
2019	410,358	$4.40M
2020	366,317	$4.04M
2021	413,641	$4.75M
2022	400,374	$4.09M
2023	330,143	$3.04M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	10%	40,578	37,601	$2.51M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	8.3%	55,413	38,714	$2.06M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	6.0%	59,304	55,507	$1.49M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	6.0%	59,260	55,458	$1.48M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	4.9%	21,754	17,687	$1.23M
80053	Comprehensive metabolic panel	3.6%	153,366	138,504	$898K
84443	Thyroid stimulating hormone (TSH)	3.4%	86,135	81,792	$843K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.7%	152,951	134,013	$677K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	2.6%	39,428	38,116	$648K
80061	Lipid panel	2.5%	84,743	80,393	$627K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.2%	35,347	33,792	$551K
87660		1.7%	28,671	27,304	$417K

271 more codes

87480		1.7%	28,689	$416K
87510		1.7%	28,669	$415K
83036	Hemoglobin; glycosylated (A1C)	1.6%	77,770	$406K
36415	Collection of venous blood by venipuncture	1.6%	214,887	$391K
87086	Culture, bacterial; quantitative colony count, urine	1.6%	74,779	$389K
82728		1.6%	45,032	$387K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.6%	29,245	$387K
80050	General health panel	1.4%	12,502	$356K
86780		1.4%	38,285	$346K
86003		1.2%	4,203	$301K
86803		1.1%	28,185	$265K
H0048	Alcohol and/or other drug testing: collection and handling only, specimens other than blood	1.0%	17,174	$255K
84439		<1%	36,280	$207K
82607		<1%	22,675	$194K
84403		<1%	11,123	$194K
86481		<1%	2,795	$158K
87077		<1%	29,483	$154K
81229		<1%	232	$153K
87186		<1%	28,244	$145K
87340		<1%	20,402	$140K
87070		<1%	21,950	$131K
82670		<1%	6,314	$125K
85027		<1%	33,493	$123K
83550		<1%	23,484	$121K
87522	Neg quan hep c or qual rna	<1%	4,579	$118K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	943	$112K
84702		<1%	9,317	$108K
83516		<1%	7,880	$100K
80048	Basic metabolic panel (calcium, ionized)	<1%	25,234	$98K
86762		<1%	9,376	$96K
83540		<1%	24,845	$96K
86235		<1%	1,928	$93K
87902		<1%	557	$93K
84270		<1%	6,285	$93K
87081		<1%	19,091	$88K
87536		<1%	1,942	$88K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	304	$82K
83970		<1%	5,016	$81K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	3,068	$80K
83001		<1%	6,001	$80K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	887	$79K
86850		<1%	12,874	$78K
87631		<1%	1,394	$76K
82784		<1%	10,559	$76K
83880		<1%	4,497	$74K
84481		<1%	6,453	$72K
82746		<1%	7,701	$67K
82570		<1%	24,511	$66K
83735		<1%	17,560	$64K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	3,408	$62K
80074		<1%	2,291	$62K
87088		<1%	12,497	$62K
86706		<1%	8,764	$58K
87529		<1%	2,275	$57K
84153		<1%	6,144	$53K
83002		<1%	3,897	$53K
84146		<1%	3,995	$52K
86480		<1%	1,323	$52K
86140		<1%	15,138	$50K
87046		<1%	4,382	$50K
86038		<1%	6,328	$49K
86704		<1%	6,424	$46K
86258		<1%	1,689	$45K
82274		<1%	4,749	$45K
81001		<1%	28,718	$45K
86376		<1%	4,433	$44K
82785		<1%	3,541	$39K
82043		<1%	13,992	$38K
86665		<1%	1,622	$37K
82105		<1%	3,270	$37K
87328		<1%	3,981	$35K
82951		<1%	3,604	$35K
86696		<1%	2,767	$35K
84144		<1%	2,339	$35K
87209		<1%	2,765	$34K
83993		<1%	2,423	$34K
80076		<1%	7,158	$34K
86800		<1%	3,056	$33K
83921		<1%	3,169	$33K
85652		<1%	18,500	$32K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	3,609	$32K
87329		<1%	3,960	$32K
82627		<1%	2,085	$32K
83655		<1%	3,573	$31K
86364		<1%	2,905	$30K
86255		<1%	3,403	$29K
87427		<1%	3,499	$28K
82533		<1%	2,743	$28K
86160		<1%	2,393	$28K
84100		<1%	10,398	$27K
84425		<1%	2,219	$27K
80069		<1%	6,972	$27K
86695		<1%	3,059	$27K
87205		<1%	10,239	$27K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,065	$26K
87338		<1%	2,752	$25K
81511		<1%	325	$25K
83690		<1%	5,599	$25K
85610		<1%	12,368	$25K
84480		<1%	2,597	$25K
84156		<1%	11,100	$24K
84550		<1%	8,405	$23K
83520		<1%	1,894	$23K
86769		<1%	1,118	$23K
86361		<1%	1,560	$22K
87045		<1%	3,496	$22K
86900		<1%	10,790	$22K
86901		<1%	10,640	$22K
82977		<1%	4,093	$22K
86141		<1%	2,553	$21K
83525		<1%	2,437	$20K
86694		<1%	1,619	$20K
82950		<1%	6,043	$20K
83498		<1%	978	$19K
86200		<1%	2,378	$18K
86231		<1%	1,538	$18K
82247		<1%	6,784	$18K
87507		<1%	55	$18K
80164		<1%	3,048	$18K
81508		<1%	518	$17K
87177		<1%	2,762	$17K
82239		<1%	1,355	$17K
86787		<1%	1,718	$17K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	1,118	$16K
80197		<1%	3,712	$16K
86664		<1%	1,464	$16K
84305		<1%	1,002	$16K
82248		<1%	5,765	$16K
86431		<1%	4,137	$15K
87799		<1%	1,590	$15K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	419	$14K
82565		<1%	3,798	$14K
86663		<1%	1,496	$14K
86677		<1%	1,372	$14K
83721		<1%	2,993	$13K
84450		<1%	3,206	$12K
82550		<1%	3,326	$12K
82747		<1%	1,189	$12K
85730		<1%	3,051	$11K
86304		<1%	890	$11K
80178		<1%	3,188	$11K
82652		<1%	494	$11K
80175		<1%	1,535	$11K
86708		<1%	1,413	$11K
86225		<1%	1,349	$11K
87324		<1%	1,493	$11K
0352U		<1%	257	$11K
83090		<1%	965	$10K
84165		<1%	2,456	$10K
82140		<1%	1,458	$10K
84703		<1%	1,896	$10K
84630		<1%	1,257	$10K
86334		<1%	1,279	$10K
84520		<1%	3,147	$10K
86039		<1%	1,385	$9K
83615		<1%	2,573	$9K
84163		<1%	621	$9K
81015		<1%	5,142	$9K
83519		<1%	653	$9K
84207		<1%	573	$8K
82150		<1%	1,828	$7K
87563		<1%	330	$7K
83521		<1%	409	$7K
80159		<1%	895	$7K
85045		<1%	2,486	$7K
82947		<1%	2,879	$7K
87497		<1%	483	$7K
85379		<1%	1,183	$7K
84134		<1%	819	$7K
82103		<1%	767	$7K
83883		<1%	754	$6K
82525		<1%	855	$6K
85246		<1%	379	$6K
87517		<1%	237	$6K
86592		<1%	2,107	$6K
82390		<1%	823	$6K
84484		<1%	876	$5K
86709		<1%	822	$5K
87254		<1%	383	$5K
86870		<1%	178	$5K
86765		<1%	440	$4K
82024		<1%	179	$4K
80177		<1%	730	$4K
85014		<1%	2,652	$4K
85245		<1%	248	$4K
84478		<1%	1,119	$4K
88142		<1%	381	$4K
85018		<1%	2,333	$4K
85240		<1%	299	$4K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	90	$4K
87493		<1%	142	$3K
86645		<1%	267	$3K
86300		<1%	358	$3K
86644		<1%	283	$3K
87102		<1%	588	$3K
87641		<1%	145	$3K
86812		<1%	156	$3K
87449		<1%	350	$3K
87430		<1%	621	$3K
82397		<1%	234	$2K
82542		<1%	155	$2K
87040		<1%	321	$2K
84681		<1%	195	$2K
88230		<1%	27	$2K
88262		<1%	26	$2K
84460		<1%	679	$2K
82310		<1%	642	$2K
82677		<1%	123	$2K
86308		<1%	495	$2K
86735		<1%	179	$2K
82330		<1%	200	$2K
86593		<1%	566	$2K
83020		<1%	159	$1K
86705		<1%	250	$1K
84155		<1%	1,045	$1K
86336		<1%	140	$1K
80156		<1%	218	$1K
83013		<1%	24	$1K
80183		<1%	106	$1K
86015		<1%	171	$937.40
82172		<1%	71	$917.36
87106		<1%	149	$897.08
86923		<1%	16	$799.24
86147		<1%	14	$770.34
86381		<1%	66	$754.10
82088		<1%	32	$740.06
87109		<1%	79	$737.38
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	1,089	$720.96
84154		<1%	97	$716.39
84244		<1%	54	$678.66
87075		<1%	158	$643.58
87101		<1%	120	$621.93
87539		<1%	20	$618.51
83021		<1%	45	$554.22
81596		<1%	28	$548.04
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	1,039	$501.70
84445		<1%	14	$500.48
86880		<1%	119	$491.25
84590		<1%	67	$487.73
87210		<1%	577	$484.20
81003		<1%	376	$467.07
84436		<1%	101	$441.89
83010		<1%	56	$434.18
83835		<1%	32	$381.76
82378		<1%	35	$363.63
80185		<1%	58	$338.54
85613		<1%	55	$329.72
0099U		<1%	63	$312.50
88289		<1%	12	$259.91
88280		<1%	12	$252.67
83876		<1%	12	$249.20
84402		<1%	16	$233.18
82340		<1%	49	$205.58
89051		<1%	60	$186.72
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	164	$162.25
83695		<1%	338	$162.08
82530		<1%	13	$156.17
83630		<1%	13	$145.75
82610		<1%	12	$127.76
84446		<1%	16	$123.03
80201		<1%	14	$122.92
82040		<1%	44	$114.37
87350		<1%	14	$104.91
85384		<1%	16	$94.24
84132		<1%	35	$84.93
82085		<1%	12	$61.20
82465		<1%	12	$58.51
84075		<1%	13	$31.29
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	17	$25.27
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	116	$22.90
89321		<1%	13	$9.09

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVUCKOVICH, PAMELA (SR VP AND CFO)

Parent organizationLEGACY EMANUEL HOSPITAL AND HEALTH CENTER